1978
DOI: 10.1001/archderm.114.8.1191
|View full text |Cite
|
Sign up to set email alerts
|

Complement-fixing pemphigus antibodies

Abstract: The serum of a patient with a typical case of pemphigus vulgaria contained complement-fixing intercellular autoantibodies (pemphigus antibodies). Complement-fixing pemphigus antibodies were demonstrated only during the untreated active stage of the disease and titrated lower than corresponding IgG autoantibodies, which paralleled well with the disease activity. Pemphigus lesional skin, which contained in-vivo-bound IgG, showed the capability of further binding C3 in vitro from normal human serum. It was sugges… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1979
1979
2016
2016

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…However, the mechanisms of blister formation in pemphigus after binding of autoantibodies to epidermal cells were largely unknown at that time. The involvement of the complement system and of proteases was intensely debated (25,27,28,(35)(36)(37)(38)(39). Further studies using F(ab 0 ) 2 and Fab fragments of IgG and mice deficient for C5 component have shown that complement is not required for the pathogenicity of pemphigus autoantibodies in vivo (40).…”
Section: Pemphigusmentioning
confidence: 99%
“…However, the mechanisms of blister formation in pemphigus after binding of autoantibodies to epidermal cells were largely unknown at that time. The involvement of the complement system and of proteases was intensely debated (25,27,28,(35)(36)(37)(38)(39). Further studies using F(ab 0 ) 2 and Fab fragments of IgG and mice deficient for C5 component have shown that complement is not required for the pathogenicity of pemphigus autoantibodies in vivo (40).…”
Section: Pemphigusmentioning
confidence: 99%
“…Complement fixing IF of normal human skin and indirect immunofluorescence of salt‐split skin for C3 was performed as described previously . cDNA transfection methods for detection of IgG and IgA antibodies to Dsc1–3 were performed by living‐cell staining using COS‐7 cells, as described previously …”
Section: Methodsmentioning
confidence: 99%
“…According to the current view, experimental acantholytic blister formation does not require the complement system (22). Circulating anti-epidermal ICS antibody in the patients' sera has not generally been believed to fix complement in vitro (24,25), although controversy has arisen in the recent literature (26)(27)(28)(29).…”
Section: Horseradish Peroxidase Labeled Antibody Methodfor Light and mentioning
confidence: 99%